Miconazole%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520vaginal%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520pessary

# Miconazole Vaginal Pessary ## Overview Miconazole is an imidazole antifungal agent used to treat vulvovaginal candidiasis (yeast infections). It is available as a vaginal pessary (suppository) for localized treatment. ## Primary Indications Treatment of symptomatic vulvovaginal candidiasis. ## Adult Dosing * **100 mg vaginal pessary:** Insert 1 pessary vaginally at bedtime for 7 consecutive days. * **200 mg vaginal pessary:** Insert 1 pessary vaginally at bedtime for 3 consecutive days. * **High-strength (e.g., 1200 mg) vaginal suppository:** Insert 1 suppository vaginally at bedtime as a single dose. Specific dosing regimens may vary based on product formulation and local protocol. ## Pediatric Dosing Dosing for pediatric patients is not well-established. Use in pediatric patients should be based on clinical judgment and may require consultation with a pediatric specialist. ## Dose Adjustments No dose adjustments are typically required for renal or hepatic impairment with vaginal administration due to minimal systemic absorption. ## Contraindications Hypersensitivity to miconazole or any component of the formulation. ## Adverse Effects Common adverse effects include vaginal itching, burning, or irritation. Allergic reactions are rare. ## Key Drug Interactions * **Warfarin:** Miconazole can inhibit CYP3A4 and CYP2C9, potentially increasing warfarin levels and the risk of bleeding. Monitor INR closely if co-administered. ## Monitoring * Assess for symptom relief (e.g., reduction in itching, burning, and discharge). * Monitor for any signs of local irritation or allergic reaction. * Monitor INR if co-administered with warfarin. ## Clinical Pearls * Complete the full course of therapy as directed, even if symptoms improve earlier. * Avoid intercourse during treatment. * The pessary may weaken latex condoms and diaphragms; consider alternative birth control methods during treatment. * If symptoms persist or worsen after completing therapy, re-evaluate for alternative diagnoses or resistant organisms. *** *Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines before making treatment decisions.*